Merck
CN
  • Blindness caused by cosmetic filler injection: a review of cause and therapy.

Blindness caused by cosmetic filler injection: a review of cause and therapy.

Plastic and reconstructive surgery (2014-11-22)
Jean D A Carruthers, Steve Fagien, Rod J Rohrich, Susan Weinkle, Alastair Carruthers
摘要

Vascular occlusion causing blindness is a rare yet greatly feared complication of the use of facial aesthetic fillers. The authors performed a review of the aesthetic literature to ascertain the reported cases of blindness and the literature reporting variations in the vascular anatomy of the human face. The authors suggest a small but potentially helpful addition to the accepted management of the acute case. Cases of blindness, mostly irreversible, from aesthetic filler injections have been reported from Asia, Europe, and North America. Autologous fat appears to be the most frequent filler causing blindness. Some cases of partial visual recovery have been reported with hyaluronic acid and calcium hydroxylapatite fillers. The sudden profusion of new medical and nonmedical aesthetic filler injectors raises a new cause for alarm about patient safety. The published reports in the medical literature are made by experienced aesthetic surgeons and thus the actual incidence may be even higher. Also, newer injectors may not be aware of the variations in the pattern of facial vascular arborization. The authors present a summary of the relevant literature to date and a suggested helpful addition to the protocols for urgent management.

材料
货号
品牌
产品描述

Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
透明质酸 钠盐 来源于公鸡鸡冠, avian glycosaminoglycan polysaccharide
Sigma-Aldrich
透明质酸 钠盐 来源于牛玻璃体液
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,000,000-1,250,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 8,000-15,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 750,000-1,000,000
Sigma-Aldrich
羟基磷灰石, puriss., meets analytical specification of Ph. Eur., BP, FCC, E341, ≥90% (calculated on glowed substance)
Sigma-Aldrich
羟基磷灰石, purum p.a., ≥90% (as Ca3(PO4)2, KT)
Sigma-Aldrich
透明质酸 钠盐 来源于兽疫链球菌, bacterial glycosaminoglycan polysaccharide
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 300,000-500,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 30,000-50,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,200
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 130,000-150,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 50,000-70,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,500,000-1,750,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 2,000,000-2,400,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 10,000-30,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 500,000-750,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 90,000-110,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 150,000-300,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 70,000-120,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,750,000-2,000,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 15,000-30,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 2,000,000-2,200,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 1,250,000-1,500,000
Sigma-Aldrich
透明质酸 钠盐 来源于马链球菌, mol wt 120,000-350,000